ICU Medical Inc: Form 10-Q for the period ended Jun 30, 2012
Filed with the SEC on Jul 20, 2012 and accepted by EDGAR at Jul 19, 2012, 21:45 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-04-01 to 2012-06-30 | $77.3m | us-gaap:Revenues |
| Revenue | 6 months2012-01-01 to 2012-06-30 | $152.8m | us-gaap:Revenues |
| Cost of revenue | 3 months2012-04-01 to 2012-06-30 | $38.2m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months2012-01-01 to 2012-06-30 | $78.7m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2012-04-01 to 2012-06-30 | $39.1m | us-gaap:GrossProfit |
| Gross profit | 6 months2012-01-01 to 2012-06-30 | $74.0m | us-gaap:GrossProfit |
| Research and development | 3 months2012-04-01 to 2012-06-30 | $2.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2012-01-01 to 2012-06-30 | $5.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2012-04-01 to 2012-06-30 | $22.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2012-01-01 to 2012-06-30 | $43.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2012-04-01 to 2012-06-30 | $13.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2012-01-01 to 2012-06-30 | $24.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2012-04-01 to 2012-06-30 | $4.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2012-01-01 to 2012-06-30 | $8.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 6 months2012-01-01 to 2012-06-30 | $16.8m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2012-04-01 to 2012-06-30 | $0.63 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2012-01-01 to 2012-06-30 | $1.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2012-04-01 to 2012-06-30 | $0.65 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2012-01-01 to 2012-06-30 | $1.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2012-04-01 to 2012-06-30 | 14,620,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2012-01-01 to 2012-06-30 | 14,484,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2012-01-01 to 2012-06-30 | $31.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2012-01-01 to 2012-06-30 | $8.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2012-06-30 | $121.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-06-30 | $293.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2012-06-30 | $392.6m | us-gaap:Assets |
| Current liabilities | At period end2012-06-30 | $29.8m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2012-06-30 | $351.5m | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
| Shares outstanding | At period end2012-06-30 | 14,268,055 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000883984-12-000080. Last ingested by Listed: Nov 14, 2026, 20:54 ET. Listed shows no prices and gives no investment advice.